%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
James K. Tsuruta, Nicholas P. Schaub, Juan D. Rojas, Jason Streeter, Nancy Klauber-DeMore, Paul Dayton
Optimizing ultrasound molecular imaging of secreted frizzled related protein 2 expression in angiosarcoma
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 13 0 R/Contents 14 0 R/TrimBox[0 0 612 792]>>
endobj
13 0 obj
[15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R]
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174281.ref001)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174281.ref002)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174281.ref003)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174281.ref004)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174281.ref002)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174281.ref005)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174281.ref006)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174281.ref007)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174281.ref008)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174281.ref008)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174281.ref009)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174281.ref010)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174281.ref011)>>
endobj
28 0 obj
<>/Border[0 0 0]/A 29 0 R>>
endobj
29 0 obj
<>
endobj
14 0 obj
[30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R]
endobj
30 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 680.2299 m
199.9998 680.2299 l
199.9998 680.73 l
575.9997 680.73 l
f*
0.83 0.64 0.02 0 k
234.085 523.8992 m
238.8472 523.8992 l
h
f*
241.115 523.8992 m
245.8772 523.8992 l
h
f*
222.0094 432.9071 m
226.7717 432.9071 l
h
f*
229.0394 432.9071 m
233.8016 432.9071 l
h
f*
485.7449 419.9244 m
490.5071 419.9244 l
h
f*
492.7748 419.9244 m
497.537 419.9244 l
h
f*
495.4961 380.9197 m
500.2583 380.9197 l
h
f*
320.9386 354.8976 m
325.7008 354.8976 l
h
f*
499.1244 289.9276 m
503.7732 289.9276 l
h
f*
479.5654 237.9402 m
484.2142 237.9402 l
h
f*
439.4268 224.9008 m
444.0756 224.9008 l
h
f*
339.0236 198.9354 m
348.378 198.9354 l
h
f*
231.1937 159.9307 m
240.7181 159.9307 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.0125 707.7543 cm
BT
/F0 1 Tf
1 TL
0.0053 Tc
0 0 Td
(specific)Tj
3.5865 0 Td
(signal)Tj
2.8526 0 Td
(returned)Tj
3.9744 0 Td
(from)Tj
2.2438 0 Td
(angiosarcoma)Tj
6.5406 0 Td
(vasculature,)Tj
5.6693 0 Td
(and)Tj
1.8917 0 Td
(may)Tj
2.1245 0 Td
(provide)Tj
3.5269 0 Td
(new)Tj
2.0588 0 Td
(opportuni-)Tj
-34.4691 -1.474 Td
(ties)Tj
1.7962 0 Td
(for)Tj
1.4024 0 Td
(targeted)Tj
3.9208 0 Td
(molecular)Tj
4.5891 0 Td
(imaging.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 619.9937 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 602.9858 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Angiogenesis)Tj
5.5388 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4683 0 Td
(formation)Tj
4.2633 0 Td
(of)Tj
1.0148 0 Td
(new)Tj
1.8765 0 Td
(capillaries)Tj
4.2066 0 Td
(from)Tj
2.2054 0 Td
(existing)Tj
3.3165 0 Td
(microvasculature.)Tj
7.336 0 Td
(There)Tj
2.5795 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
-35.5065 -1.2982 Td
(critical)Tj
2.948 0 Td
(need)Tj
2.1429 0 Td
(for)Tj
1.389 0 Td
(non-invasive)Tj
5.3858 0 Td
(imaging)Tj
3.4866 0 Td
(techniques)Tj
4.5241 0 Td
(that)Tj
1.7801 0 Td
(examine)Tj
3.6 0 Td
(molecular)Tj
4.2236 0 Td
(events)Tj
2.7269 0 Td
(associated)Tj
-32.207 -1.2983 Td
(with)Tj
1.9955 0 Td
(the)Tj
1.4684 0 Td
(angiogenic)Tj
4.5694 0 Td
(process)Tj
3.1861 0 Td
(that)Tj
1.7802 0 Td
(could)Tj
2.4491 0 Td
(prove)Tj
2.4944 0 Td
(invaluable)Tj
4.3087 0 Td
(for)Tj
1.3889 0 Td
(improving)Tj
4.4391 0 Td
(specificity)Tj
4.2066 0 Td
(for)Tj
1.3889 0 Td
(diagnos-)Tj
-33.6753 -1.3039 Td
(ing)Tj
1.5023 0 Td
(malignancies.)Tj
5.6806 0 Td
(One)Tj
1.9389 0 Td
(strategy)Tj
3.3278 0 Td
(for)Tj
1.3833 0 Td
(studying)Tj
3.6737 0 Td
(angiogenesis)Tj
5.2894 0 Td
(is)Tj
0.8504 0 Td
(ultrasound)Tj
4.5694 0 Td
(molecular)Tj
4.218 0 Td
(imaging,)Tj
-32.4338 -1.2983 Td
(which)Tj
2.6475 0 Td
(differs)Tj
2.7496 0 Td
(from)Tj
2.2053 0 Td
(traditional)Tj
4.4164 0 Td
(ultrasound)Tj
4.5694 0 Td
(imaging)Tj
3.4866 0 Td
(in)Tj
1.0375 0 Td
(that)Tj
1.7801 0 Td
(targeted)Tj
3.4583 0 Td
(contrast)Tj
3.4639 0 Td
(agents)Tj
2.7496 0 Td
(selectively)Tj
-32.5642 -1.2982 Td
(adhere)Tj
2.9253 0 Td
(to)Tj
1.0261 0 Td
(endothelial)Tj
4.6715 0 Td
(biomarkers)Tj
4.7792 0 Td
(of)Tj
1.0148 0 Td
(interest,)Tj
3.4355 0 Td
(such)Tj
2.058 0 Td
(as)Tj
1.0148 0 Td
(markers)Tj
3.4979 0 Td
(over-expressed)Tj
6.2022 0 Td
(in)Tj
1.0374 0 Td
(tumor)Tj
2.744 0 Td
(angio-)Tj
-34.4067 -1.3039 Td
(genesis)Tj
3.067 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(].)Tj
-1.8708 -1.2983 Td
(Biomarkers)Tj
4.8528 0 Td
(specific)Tj
3.1918 0 Td
(to)Tj
1.0262 0 Td
(tumors)Tj
3.1011 0 Td
(could)Tj
2.4547 0 Td
(increase)Tj
3.4753 0 Td
(the)Tj
1.4683 0 Td
(sensitivity)Tj
4.218 0 Td
(and)Tj
1.7348 0 Td
(specificity)Tj
4.2065 0 Td
(of)Tj
1.0148 0 Td
(traditional)Tj
-31.9405 -1.2983 Td
(imaging)Tj
3.4865 0 Td
(techniques.)Tj
4.7509 0 Td
(In)Tj
1.1112 0 Td
(ultrasound)Tj
4.5694 0 Td
(molecular)Tj
4.2179 0 Td
(imaging,)Tj
3.7134 0 Td
(targeted)Tj
3.4582 0 Td
(microbubble)Tj
5.3291 0 Td
(contrast)Tj
3.4639 0 Td
(binds)Tj
2.4321 0 Td
(to)Tj
-36.5326 -1.3039 Td
(endothelial)Tj
4.6657 0 Td
(markers)Tj
3.498 0 Td
(directed)Tj
3.4866 0 Td
(by)Tj
1.1792 0 Td
(a)Tj
0.6519 0 Td
(targeting)Tj
3.7928 0 Td
(moiety)Tj
2.9933 0 Td
(such)Tj
2.058 0 Td
(as)Tj
1.0148 0 Td
(an)Tj
1.2019 0 Td
(antibody)Tj
3.7643 0 Td
(or)Tj
1.0999 0 Td
(receptor)Tj
3.5546 0 Td
(ligand.)Tj
-32.961 -1.2983 Td
(Bound)Tj
2.9083 0 Td
(microbubbles,)Tj
5.913 0 Td
(under)Tj
2.6192 0 Td
(ultrasound)Tj
4.5694 0 Td
(energy,)Tj
3.1351 0 Td
(then)Tj
2.0183 0 Td
(display)Tj
3.0274 0 Td
(detectable)Tj
4.2236 0 Td
(acoustic)Tj
3.4639 0 Td
(backscatter.)Tj
-31.8782 -1.2982 Td
(Several)Tj
3.05 0 Td
(potential)Tj
3.7587 0 Td
(applications)Tj
5.04 0 Td
(of)Tj
1.0148 0 Td
(ultrasound)Tj
4.5694 0 Td
(molecular)Tj
4.2179 0 Td
(imaging)Tj
3.4866 0 Td
(exist.)Tj
2.2621 0 Td
(Molecular)Tj
4.2916 0 Td
(imaging)Tj
3.4866 0 Td
(of)Tj
-35.1777 -1.2983 Td
(tumor)Tj
2.7439 0 Td
(endothelial)Tj
4.6714 0 Td
(markers)Tj
3.4923 0 Td
(may)Tj
1.9332 0 Td
(help)Tj
1.9332 0 Td
(better)Tj
2.5399 0 Td
(discriminate)Tj
5.2327 0 Td
(between)Tj
3.5263 0 Td
(benign)Tj
2.982 0 Td
(and)Tj
1.7291 0 Td
(malignant)Tj
4.2803 0 Td
(dis-)Tj
-35.0643 -1.3039 Td
(ease)Tj
1.8595 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
2.3017 0 Td
(After)Tj
2.2847 0 Td
(tumor)Tj
2.7439 0 Td
(treatment,)Tj
4.3653 0 Td
(molecular)Tj
4.218 0 Td
(imaging)Tj
3.4866 0 Td
(may)Tj
1.9275 0 Td
(provide)Tj
3.2882 0 Td
(early)Tj
2.1486 0 Td
(indication)Tj
4.3087 0 Td
(of)Tj
1.0148 0 Td
(tumor)Tj
-33.9475 -1.2983 Td
(response,)Tj
3.9571 0 Td
(as)Tj
1.0148 0 Td
(molecular)Tj
4.2179 0 Td
(changes)Tj
3.4072 0 Td
(may)Tj
1.9276 0 Td
(precede)Tj
3.3278 0 Td
(changes)Tj
3.4016 0 Td
(in)Tj
1.0375 0 Td
(tumor)Tj
2.7439 0 Td
(volume)Tj
3.1974 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
-27.0366 -1.2982 Td
(Ultrasound)Tj
4.7791 0 Td
(has)Tj
1.5421 0 Td
(several)Tj
2.9367 0 Td
(advantages)Tj
4.5977 0 Td
(over)Tj
1.9786 0 Td
(other)Tj
2.3471 0 Td
(imaging)Tj
3.4866 0 Td
(modalities)Tj
4.371 0 Td
(such)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(MRI)Tj
2.0749 0 Td
(and)Tj
1.7291 0 Td
(CT.)Tj
-34.1175 -1.3039 Td
(MRI)Tj
2.0749 0 Td
(is)Tj
0.8447 0 Td
(expensive,)Tj
4.3313 0 Td
(slow,)Tj
2.2451 0 Td
(and)Tj
1.7291 0 Td
(not)Tj
1.576 0 Td
(widely)Tj
2.8233 0 Td
(available)Tj
3.6624 0 Td
(in)Tj
1.0374 0 Td
(rural)Tj
2.1714 0 Td
(locations.)Tj
4.0365 0 Td
(The)Tj
1.7801 0 Td
(cost)Tj
1.8142 0 Td
(of)Tj
1.0148 0 Td
(portable)Tj
3.5206 0 Td
(ultra-)Tj
-34.6618 -1.2983 Td
(sound)Tj
2.6928 0 Td
(systems)Tj
3.2996 0 Td
(is)Tj
0.8447 0 Td
(very)Tj
1.9275 0 Td
(affordabletypically)Tj
8.5096 0 Td
(only)Tj
1.9785 0 Td
(1/100th)Tj
3.2769 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.6519 0 Td
(MRI)Tj
2.075 0 Td
(system)Tj
2.9367 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(],)Tj
1.6044 0 Td
(and)Tj
1.7291 0 Td
(unlike)Tj
2.7326 0 Td
(CT)Tj
-35.2741 -1.2983 Td
(scans,)Tj
2.5738 0 Td
(ultrasound)Tj
4.5694 0 Td
(does)Tj
2.0353 0 Td
(not)Tj
1.576 0 Td
(require)Tj
3.1124 0 Td
(ionizing)Tj
3.5036 0 Td
(radiation,)Tj
4.0989 0 Td
(and)Tj
1.7291 0 Td
(clinically)Tj
3.7814 0 Td
(approved)Tj
3.9685 0 Td
(ultrasound)Tj
4.5694 0 Td
(con-)Tj
-35.5178 -1.3039 Td
(trast)Tj
1.9842 0 Td
(agents)Tj
2.7496 0 Td
(are)Tj
1.4456 0 Td
(well)Tj
1.8199 0 Td
(tolerated)Tj
3.753 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
-0.012 Tc
-10.5561 -1.2983 Td
(The)Tj
1.7631 0 Td
(development)Tj
5.3178 0 Td
(of)Tj
1.0034 0 Td
(strategies)Tj
3.8381 0 Td
(for)Tj
1.3663 0 Td
(monitoring)Tj
4.7395 0 Td
(the)Tj
1.4457 0 Td
(angiogenic)Tj
4.49 0 Td
(process)Tj
3.1294 0 Td
(depends)Tj
3.4923 0 Td
(upon)Tj
2.2847 0 Td
(identify-)Tj
-34.0665 -1.2982 Td
(ing)Tj
1.474 0 Td
(targets)Tj
2.8119 0 Td
(with)Tj
1.9672 0 Td
(biosignatures)Tj
5.4539 0 Td
(unique)Tj
2.9707 0 Td
(to)Tj
1.0091 0 Td
(tumor)Tj
2.7042 0 Td
(angiogenesis.)Tj
5.4085 0 Td
(To)Tj
1.3209 0 Td
(discover)Tj
3.4923 0 Td
(proteins)Tj
3.4469 0 Td
(overexpressed)Tj
-32.0596 -1.2983 Td
(in)Tj
1.0204 0 Td
(tumor)Tj
2.7043 0 Td
(vessels,)Tj
3.0103 0 Td
(we)Tj
1.3096 0 Td
(developed)Tj
4.2009 0 Td
(a)Tj
0.6463 0 Td
(novel)Tj
2.3584 0 Td
(method)Tj
3.2769 0 Td
(for)Tj
1.3606 0 Td
(immuno-laser)Tj
5.7996 0 Td
(capture)Tj
3.1635 0 Td
(microdissection)Tj
6.4743 0 Td
(cou-)Tj
-35.3251 -1.3039 Td
(pled)Tj
1.8992 0 Td
(with)Tj
1.9672 0 Td
(RNA)Tj
2.2393 0 Td
(amplification)Tj
5.4312 0 Td
(and)Tj
1.7064 0 Td
(genome-wide)Tj
5.5729 0 Td
(gene)Tj
2.0523 0 Td
(expression)Tj
4.3823 0 Td
(to)Tj
1.0091 0 Td
(profile)Tj
2.7836 0 Td
(tumor)Tj
2.7043 0 Td
(vasculature)Tj
-31.7478 -1.2983 Td
(cells)Tj
1.8765 0 Td
(from)Tj
2.177 0 Td
(human)Tj
3.0387 0 Td
(breast)Tj
2.5682 0 Td
(tumors)Tj
3.0557 0 Td
(with)Tj
1.9616 0 Td
(comparison)Tj
4.8982 0 Td
(to)Tj
1.0091 0 Td
(normal)Tj
3.1011 0 Td
(breast)Tj
2.5682 0 Td
(samples)Tj
3.3222 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
1.5703 0 Td
(In)Tj
1.0942 0 Td
(our)Tj
1.5987 0 Td
(analysis,)Tj
-33.8397 -1.2982 Td
(we)Tj
1.3095 0 Td
(identified)Tj
3.9799 0 Td
(that)Tj
1.7461 0 Td
(secreted)Tj
3.4072 0 Td
(frizzle)Tj
2.5852 0 Td
(related)Tj
2.8913 0 Td
(protein)Tj
3.0954 0 Td
(2)Tj
0.6917 0 Td
(\(SFRP2\))Tj
3.5036 0 Td
(mRNA)Tj
3.05 0 Td
(was)Tj
1.6725 0 Td
(increased)Tj
3.9288 0 Td
(more)Tj
2.3074 0 Td
(than)Tj
-34.1686 -1.304 Td
(6-fold)Tj
2.5681 0 Td
(in)Tj
1.0148 0 Td
(breast)Tj
2.5682 0 Td
(cancer)Tj
2.7949 0 Td
(endothelium.)Tj
5.4709 0 Td
(We)Tj
1.593 0 Td
(validated)Tj
3.7587 0 Td
(localization)Tj
4.7169 0 Td
(and)Tj
1.7064 0 Td
(overexpression)Tj
6.1115 0 Td
(of)Tj
0.9978 0 Td
(SFRP2)Tj
2.8403 0 Td
(in)Tj
-36.1415 -1.2982 Td
(tumor)Tj
2.7042 0 Td
(endothelium)Tj
5.2497 0 Td
(at)Tj
0.9354 0 Td
(the)Tj
1.4457 0 Td
(protein)Tj
3.0954 0 Td
(level)Tj
1.9729 0 Td
(as)Tj
1.0035 0 Td
(shown)Tj
2.8063 0 Td
(by)Tj
1.1678 0 Td
(immunohistochemistry)Tj
9.4563 0 Td
(in)Tj
1.0205 0 Td
(breast,)Tj
2.7836 0 Td
(colon,)Tj
-33.6413 -1.2983 Td
(pancreas,)Tj
3.8834 0 Td
(renal,)Tj
2.4208 0 Td
(prostate,)Tj
3.5886 0 Td
(hepatocellular)Tj
5.7316 0 Td
(carcinoma,)Tj
4.5921 0 Td
(and)Tj
1.7065 0 Td
(angiosarcoma)Tj
5.6976 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
1.5703 0 Td
(We)Tj
1.5931 0 Td
(further)Tj
2.9707 0 Td
(discov-)Tj
-33.7547 -1.3039 Td
(ered)Tj
1.9332 0 Td
(that)Tj
1.7461 0 Td
(SFRP2)Tj
2.8403 0 Td
(is)Tj
0.8334 0 Td
(a)Tj
0.6463 0 Td
(novel)Tj
2.3584 0 Td
(stimulator)Tj
4.2689 0 Td
(of)Tj
0.9978 0 Td
(angiogenesis)Tj
/F12 1 Tf
5.1987 0 Td
[()12()]TJ
0.9978 0 Td
[()-13()15()3()]TJ
/F8 1 Tf
1.7858 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(])Tj
1.355 0 Td
(and)Tj
/F12 1 Tf
1.7064 0 Td
[()12()]TJ
0.9978 0 Td
[()-13()14()7()20()]TJ
/F8 1 Tf
(,)Tj
2.2224 0 Td
(and)Tj
1.7064 0 Td
(that)Tj
1.7461 0 Td
(antago-)Tj
-33.3408 -1.2983 Td
(nism)Tj
2.1826 0 Td
(of)Tj
0.9978 0 Td
(SFRP2)Tj
2.8403 0 Td
(with)Tj
1.9672 0 Td
(a)Tj
0.6463 0 Td
(mouse)Tj
2.8176 0 Td
(monoclonal)Tj
4.9266 0 Td
(antibody)Tj
3.7021 0 Td
(inhibited)Tj
3.7813 0 Td
(triple)Tj
2.2961 0 Td
(negative)Tj
3.4696 0 Td
(breast)Tj
2.5682 0 Td
(carcinoma)Tj
-32.1957 -1.2982 Td
(and)Tj
1.7064 0 Td
(angiosarcoma)Tj
5.6919 0 Td
(growth)Tj
3.0274 0 Td
(in)Tj
1.0205 0 Td
(mice)Tj
2.1203 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
-0.004 Tc
-12.3703 -1.3039 Td
(We)Tj
1.61 0 Td
(previously)Tj
4.354 0 Td
(created)Tj
3.1181 0 Td
(an)Tj
1.2019 0 Td
(antibody-labeled)Tj
6.9278 0 Td
(contrast)Tj
3.4583 0 Td
(by)Tj
1.1848 0 Td
(conjugating)Tj
4.9606 0 Td
(biotinylated)Tj
5.0003 0 Td
(polyclonal)Tj
-33.012 -1.2983 Td
(SFRP2)Tj
2.8799 0 Td
(antibodies)Tj
4.3597 0 Td
(to)Tj
1.0261 0 Td
(biotin-activated)Tj
6.5253 0 Td
(microbubble)Tj
5.3291 0 Td
(ultrasound)Tj
4.5695 0 Td
(contrast)Tj
3.4582 0 Td
(using)Tj
2.3924 0 Td
(a)Tj
0.652 0 Td
(streptavidin)Tj
-31.1922 -1.2983 Td
(bridge)Tj
2.7779 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
2.0806 0 Td
(We)Tj
1.6101 0 Td
(demonstrated)Tj
5.7599 0 Td
(that)Tj
1.7745 0 Td
(ultrasound)Tj
4.5694 0 Td
(molecular)Tj
4.2236 0 Td
(imaging)Tj
3.4866 0 Td
(using)Tj
2.3868 0 Td
(SFRP2-targeted)Tj
6.4743 0 Td
(con-)Tj
-35.1437 -1.2982 Td
(trast)Tj
1.9842 0 Td
(increased)Tj
3.9968 0 Td
(the)Tj
1.4684 0 Td
(average)Tj
3.2258 0 Td
(video)Tj
2.4037 0 Td
(pixel)Tj
2.1373 0 Td
(intensity)Tj
3.6907 0 Td
(\(VI\))Tj
1.9332 0 Td
(of)Tj
1.0148 0 Td
(angiosarcoma)Tj
5.7883 0 Td
(vessels)Tj
2.8517 0 Td
(by)Tj
1.1849 0 Td
(2.2)Tj
/F13 1 Tf
1.3946 0 Td
[()]TJ
/F8 1 Tf
0.788 0 Td
(0.6)Tj
1.4003 0 Td
(VI)Tj
-35.2627 -1.304 Td
(compared)Tj
4.2406 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4683 0 Td
(streptavidin)Tj
4.989 0 Td
(control.)Tj
3.3505 0 Td
(However,)Tj
4.0762 0 Td
(background)Tj
5.0286 0 Td
(binding)Tj
3.3506 0 Td
(of)Tj
1.0148 0 Td
(our)Tj
1.627 0 Td
(control)Tj
3.1238 0 Td
(contrast)Tj
-33.2955 -1.2982 Td
(was)Tj
1.6951 0 Td
(higher)Tj
2.8062 0 Td
(than)Tj
2.0296 0 Td
(expected)Tj
3.7191 0 Td
(and)Tj
1.7291 0 Td
(we)Tj
1.3323 0 Td
(sought)Tj
2.9026 0 Td
(to)Tj
1.0262 0 Td
(optimize)Tj
3.736 0 Td
(our)Tj
1.6271 0 Td
(method)Tj
3.3222 0 Td
(to)Tj
1.0261 0 Td
(improve)Tj
3.5773 0 Td
(specificity.)Tj
4.439 0 Td
(In)Tj
1.1055 0 Td
(this)Tj
-36.0734 -1.2983 Td
(study,)Tj
2.6135 0 Td
(we)Tj
1.3266 0 Td
(hypothesized)Tj
5.4708 0 Td
(that)Tj
1.7802 0 Td
(optimizations)Tj
5.7202 0 Td
(to)Tj
1.0262 0 Td
(our)Tj
1.6271 0 Td
(molecular)Tj
4.2179 0 Td
(imaging)Tj
3.4866 0 Td
(reagents,)Tj
3.77 0 Td
(and)Tj
1.7348 0 Td
(protocol)Tj
-32.7739 -1.3039 Td
(could)Tj
2.4491 0 Td
(significantly)Tj
5.091 0 Td
(increase)Tj
3.4752 0 Td
(the)Tj
1.4684 0 Td
(average)Tj
3.2258 0 Td
(video)Tj
2.3981 0 Td
(pixel)Tj
2.1373 0 Td
(intensity)Tj
3.6906 0 Td
(of)Tj
1.0148 0 Td
(angiosarcoma)Tj
5.794 0 Td
(vasculature)Tj
-30.7443 -1.2983 Td
(imaged)Tj
3.1577 0 Td
(with)Tj
1.9956 0 Td
(SFRP2-targeted)Tj
6.4743 0 Td
(contrast)Tj
3.4582 0 Td
(agent.)Tj
2.6136 0 Td
(We)Tj
1.61 0 Td
(optimized)Tj
4.2633 0 Td
(five)Tj
1.6498 0 Td
(design)Tj
2.8176 0 Td
(parameters:)Tj
4.8982 0 Td
(\(1\))Tj
1.3777 0 Td
(we)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 301.1527 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Optimizin)Tj
4.096 0 Td
(g)Tj
0.7654 0 Td
(ultrasound)Tj
4.8048 0 Td
(molecular)Tj
4.4717 0 Td
(imaging)Tj
3.6496 0 Td
(of)Tj
1.0417 0 Td
(SFRP2)Tj
3.4087 0 Td
(expression)Tj
4.9678 0 Td
(in)Tj
0.9779 0 Td
(angiosa)Tj
3.43 0 Td
(rcoma)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01742)Tj
4.089 0 Td
(81)Tj
0 g
2.0906 0 Td
(March)Tj
2.9622 0 Td
(23,)Tj
1.5874 0 Td
(2017)Tj
34.3562 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(21)Tj
/F10 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(NKD)Tj
1.9204 0 Td
(Methods)Tj
3.4938 0 Td
(and)Tj
1.5874 0 Td
(Composition)Tj
4.7055 0 Td
(s)Tj
0.6449 0 Td
(for)Tj
1.2544 0 Td
(Tumor)Tj
-13.6064 -1.3748 Td
(Vasculatur)Tj
3.9118 0 Td
(e)Tj
0.6449 0 Td
(Imaging)Tj
3.2598 0 Td
(and)Tj
1.5875 0 Td
(Targeted)Tj
3.4724 0 Td
(Therapy,)Tj
-12.8764 -1.3749 Td
(Provisional)Tj
4.3157 0 Td
(patent)Tj
2.5229 0 Td
(applicatio)Tj
3.515 0 Td
(n)Tj
0.6945 0 Td
(no.)Tj
1.389 0 Td
(61/877,526)Tj
4.4929 0 Td
(filed)Tj
-16.93 -1.3748 Td
(9/13/13)Tj
3.0968 0 Td
(and)Tj
1.5874 0 Td
(a)Tj
0.6449 0 Td
(Researc)Tj
2.9977 0 Td
(h)Tj
0.6945 0 Td
(Grant)Tj
2.2677 0 Td
(\(JT,)Tj
1.6441 0 Td
(PD,)Tj
1.5591 0 Td
(NKD\))Tj
-14.4922 -1.3748 Td
(1U01CA1)Tj
3.5291 0 Td
(89281-01A1)Tj
4.6205 0 Td
(.)Tj
0.4465 0 Td
(This)Tj
1.7787 0 Td
(does)Tj
2.0126 0 Td
(not)Tj
1.4245 0 Td
(alter)Tj
1.8142 0 Td
(our)Tj
-15.6261 -1.3748 Td
(adherence)Tj
4.0535 0 Td
(to)Tj
0.9496 0 Td
(PLOS)Tj
2.3316 0 Td
(ONE)Tj
1.8708 0 Td
(policies)Tj
3.0119 0 Td
(on)Tj
1.1622 0 Td
(sharing)Tj
2.9835 0 Td
(data)Tj
-16.3631 -1.3748 Td
(and)Tj
ET
endstream
endobj
31 0 obj
<>stream
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
BT
1.5874 75.8415 Td
(materials.)Tj
ET
Q
endstream
endobj
43 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 44 0 R/Contents 45 0 R/TrimBox[0 0 612 792]>>
endobj
44 0 obj
[46 0 R]
endobj
46 0 obj
<>/Border[0 0 0]/A 47 0 R>>
endobj
47 0 obj
<>
endobj
45 0 obj
[48 0 R 49 0 R 50 0 R 51 0 R]
endobj
48 0 obj
<>stream
q
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(decreased)Tj
4.1328 0 Td
(non-specific)Tj
5.1477 0 Td
(binding)Tj
3.3506 0 Td
(by)Tj
1.1792 0 Td
(using)Tj
2.3924 0 Td
(NeutrAvidin)Tj
/F13 1 Tf
[()]TJ
/F8 1 Tf
(-activated)Tj
9.6944 0 Td
(microbubbles,)Tj
5.913 0 Td
(and)Tj
1.7292 0 Td
(elimi-)Tj
-33.5393 -1.3039 Td
(nated)Tj
2.4491 0 Td
(microbubble)Tj
5.3291 0 Td
(aggregation)Tj
4.8982 0 Td
(by)Tj
1.1792 0 Td
(using)Tj
2.3924 0 Td
(a)Tj
0.652 0 Td
(maleimide-thiol)Tj
6.6444 0 Td
(linkage)Tj
3.1011 0 Td
(rather)Tj
2.6475 0 Td
(than)Tj
2.0296 0 Td
(using)Tj
2.3924 0 Td
(a)Tj
0.652 0 Td
(strepta-)Tj
-34.367 -1.2982 Td
(vidin)Tj
2.2847 0 Td
(bridge)Tj
2.7836 0 Td
(between)Tj
3.5262 0 Td
(biotinylated)Tj
5.0003 0 Td
(antibodies)Tj
4.3597 0 Td
(and)Tj
1.7291 0 Td
(microbubbles,)Tj
5.913 0 Td
(\(2\))Tj
1.3777 0 Td
(we)Tj
1.3266 0 Td
(decreased)Tj
4.1385 0 Td
(non-specific)Tj
-32.4394 -1.2983 Td
(binding)Tj
3.3505 0 Td
(further)Tj
3.0274 0 Td
(by)Tj
1.1792 0 Td
(targeting)Tj
3.7927 0 Td
(our)Tj
1.6271 0 Td
(control)Tj
3.1237 0 Td
(contrast)Tj
3.4583 0 Td
(with)Tj
2.0012 0 Td
(antibodies)Tj
4.3597 0 Td
(against)Tj
3.0274 0 Td
(chicken)Tj
3.3278 0 Td
(IgY,)Tj
1.8879 0 Td
(\(3\))Tj
1.3719 0 Td
(we)Tj
-35.5348 -1.2983 Td
(used)Tj
2.0579 0 Td
(time-intensity)Tj
5.845 0 Td
(curves)Tj
2.7836 0 Td
(\(TIC\))Tj
2.5171 0 Td
(from)Tj
2.2054 0 Td
(non-tumor)Tj
4.6998 0 Td
(regions)Tj
3.1634 0 Td
(of)Tj
1.0148 0 Td
(interest)Tj
3.2088 0 Td
(\(ROI\))Tj
2.6079 0 Td
(to)Tj
1.0261 0 Td
(generate)Tj
3.6057 0 Td
(free-)Tj
-34.7355 -1.3039 Td
(flowing-)Tj
3.5773 0 Td
(corrected)Tj
3.9854 0 Td
(TICs)Tj
2.1997 0 Td
(for)Tj
1.3833 0 Td
(both)Tj
2.0636 0 Td
(SFRP2-targeted,)Tj
6.6954 0 Td
(and)Tj
1.7291 0 Td
(IgY-targeted)Tj
5.2498 0 Td
(contrast,)Tj
3.685 0 Td
(which)Tj
2.6532 0 Td
(allowed)Tj
3.2882 0 Td
(us)Tj
-36.51 -1.2982 Td
(to)Tj
1.0261 0 Td
(time)Tj
2.0239 0 Td
(our)Tj
1.6271 0 Td
(molecular)Tj
4.2179 0 Td
(imaging)Tj
3.4866 0 Td
(acquisition)Tj
4.6318 0 Td
(to)Tj
1.0261 0 Td
(occur)Tj
2.4718 0 Td
(when)Tj
2.4038 0 Td
(the)Tj
1.4683 0 Td
(ratio)Tj
2.0976 0 Td
(between)Tj
3.532 0 Td
(SFRP2-specific)Tj
-30.013 -1.2983 Td
(and)Tj
1.7291 0 Td
(IgY-specific)Tj
4.9776 0 Td
(acoustic)Tj
3.4639 0 Td
(signals)Tj
2.9027 0 Td
(was)Tj
1.7007 0 Td
(at)Tj
0.9525 0 Td
(its)Tj
1.1452 0 Td
(maximum,)Tj
4.5977 0 Td
(\(4\))Tj
1.3777 0 Td
(we)Tj
1.3266 0 Td
(varied)Tj
2.6985 0 Td
(the)Tj
1.4684 0 Td
(antibody-labeling)Tj
-28.3406 -1.3039 Td
(index,)Tj
2.6758 0 Td
(and)Tj
1.7292 0 Td
(\(5\))Tj
1.3776 0 Td
(we)Tj
1.3266 0 Td
(varied)Tj
2.6986 0 Td
(the)Tj
1.4683 0 Td
(dose)Tj
2.0409 0 Td
(of)Tj
1.0148 0 Td
(targeted)Tj
3.4639 0 Td
(microbubbles.)Tj
5.9131 0 Td
(We)Tj
1.6044 0 Td
(then)Tj
2.0182 0 Td
(applied)Tj
3.1578 0 Td
(these)Tj
2.2507 0 Td
(optimiza-)Tj
-32.7399 -1.2983 Td
(tions)Tj
2.1996 0 Td
(to)Tj
1.0262 0 Td
(determine)Tj
4.3256 0 Td
(the)Tj
1.4683 0 Td
(performance)Tj
5.3461 0 Td
(of)Tj
1.0148 0 Td
(our)Tj
1.6271 0 Td
(optimized)Tj
4.2576 0 Td
(SFRP2-targeted)Tj
6.4743 0 Td
(contrast)Tj
3.4639 0 Td
(in)Tj
1.0318 0 Td
(imaging)Tj
-32.2353 -1.2983 Td
(angiosarcoma)Tj
5.7883 0 Td
(tumors)Tj
3.1067 0 Td
(in)Tj
1.0375 0 Td
(a)Tj
0.652 0 Td
(murine)Tj
3.1804 0 Td
(allograft)Tj
3.5093 0 Td
(model.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 538.1858 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Material)Tj
3.959 0 Td
(and)Tj
1.989 0 Td
(methods)Tj
/F0 1 Tf
-5.948 -1.4976 Td
(Cell)Tj
1.9134 0 Td
(culture)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 503.2062 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Murine)Tj
3.2484 0 Td
(SVR)Tj
2.0126 0 Td
(angiosarcoma)Tj
5.794 0 Td
(cells)Tj
1.9162 0 Td
(were)Tj
2.126 0 Td
(acquired)Tj
3.702 0 Td
(from)Tj
2.2053 0 Td
(American)Tj
4.1896 0 Td
(Type)Tj
2.228 0 Td
(Culture)Tj
3.2769 0 Td
(Collection)Tj
-30.699 -1.2982 Td
(\(ATCC,)Tj
3.4072 0 Td
(Manassas,)Tj
4.2689 0 Td
(VA\).)Tj
2.1657 0 Td
(ATCC)Tj
2.8403 0 Td
(authenticates)Tj
5.4878 0 Td
(cell)Tj
1.5591 0 Td
(line)Tj
1.7064 0 Td
(identity;)Tj
3.532 0 Td
(furthermore,)Tj
5.3744 0 Td
(SVR)Tj
2.0069 0 Td
(angiosar-)Tj
-32.3487 -1.3039 Td
(coma)Tj
2.4037 0 Td
(cells)Tj
1.9219 0 Td
(tested)Tj
2.5512 0 Td
(negative)Tj
3.5319 0 Td
(for)Tj
1.389 0 Td
(Ectromelia,)Tj
4.8018 0 Td
(EDIM,)Tj
2.9877 0 Td
(LCMV,)Tj
3.2315 0 Td
(LDEV,)Tj
2.9877 0 Td
(MHV,)Tj
2.7949 0 Td
(MNV,)Tj
2.7723 0 Td
(MPV,)Tj
2.5909 0 Td
(MVM,)Tj
-33.9645 -1.2983 Td
(Mycoplasma,)Tj
5.5331 0 Td
(Polyoma,)Tj
3.9742 0 Td
(PVM,)Tj
2.5908 0 Td
(REO3,)Tj
2.8573 0 Td
(Sendai,)Tj
3.1238 0 Td
(TME)Tj
2.2904 0 Td
(GFVII)Tj
2.8403 0 Td
(using)Tj
2.3924 0 Td
(PCR)Tj
2.0636 0 Td
(analysis)Tj
3.3222 0 Td
(performed)Tj
4.473 0 Td
(by)Tj
-35.4611 -1.2983 Td
(Research)Tj
3.804 0 Td
(Analytic)Tj
3.5773 0 Td
(Diagnostic)Tj
4.5298 0 Td
(Laboratory)Tj
4.6431 0 Td
(\(Columbia,)Tj
4.7565 0 Td
(MO\).)Tj
2.4208 0 Td
(Cells)Tj
2.1599 0 Td
(were)Tj
2.126 0 Td
(cultured)Tj
3.566 0 Td
(in)Tj
1.0374 0 Td
(high-glu-)Tj
-32.6208 -1.3039 Td
(cose)Tj
1.9332 0 Td
(DMEM)Tj
3.3108 0 Td
(with)Tj
1.9956 0 Td
(10%)Tj
1.9332 0 Td
(fetal)Tj
1.9049 0 Td
(bovine)Tj
2.931 0 Td
(serum)Tj
2.7212 0 Td
(\(Sigma)Tj
3.0217 0 Td
(Aldrich,)Tj
3.4923 0 Td
(St.)Tj
1.2189 0 Td
(Louis,)Tj
2.6475 0 Td
(MO\))Tj
2.1997 0 Td
(and)Tj
1.7291 0 Td
(incubated)Tj
4.1783 0 Td
(in)Tj
1.0374 0 Td
(a)Tj
-36.2548 -1.2982 Td
(37C)Tj
2.228 0 Td
(humidified)Tj
4.6601 0 Td
(room)Tj
2.4264 0 Td
(air)Tj
1.2926 0 Td
(atmosphere)Tj
4.9039 0 Td
(enriched)Tj
3.7304 0 Td
(with)Tj
1.9956 0 Td
(5%)Tj
1.457 0 Td
(CO2.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 386.022 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Animal)Tj
3.2362 0 Td
(care)Tj
2.1449 0 Td
(and)Tj
1.8662 0 Td
(husbandry)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 369.0141 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(All)Tj
1.3946 0 Td
(animal)Tj
2.9707 0 Td
(experiments)Tj
5.1363 0 Td
(were)Tj
2.126 0 Td
(performed)Tj
4.4674 0 Td
(in)Tj
1.0374 0 Td
(accordance)Tj
4.7339 0 Td
(with)Tj
2.0012 0 Td
(the)Tj
1.4684 0 Td
(recommendations)Tj
7.5004 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
-33.8681 -1.3039 Td
(Guide)Tj
2.6815 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.474 0 Td
(Care)Tj
2.109 0 Td
(and)Tj
1.7291 0 Td
(Use)Tj
1.7405 0 Td
(of)Tj
1.0148 0 Td
(Laboratory)Tj
4.6431 0 Td
(Animals)Tj
3.5829 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(National)Tj
3.6907 0 Td
(Institutes)Tj
3.9458 0 Td
(of)Tj
1.0148 0 Td
(Health.)Tj
3.1407 0 Td
(The)Tj
-34.6334 -1.2982 Td
(Institutional)Tj
5.159 0 Td
(Animal)Tj
3.2201 0 Td
(Care)Tj
2.1146 0 Td
(and)Tj
1.7292 0 Td
(Use)Tj
1.7404 0 Td
(Committee)Tj
4.7395 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(University)Tj
4.405 0 Td
(of)Tj
1.0148 0 Td
(North)Tj
2.6588 0 Td
(Carolina)Tj
3.6907 0 Td
(at)Tj
0.9525 0 Td
(Chapel)Tj
-33.9078 -1.2983 Td
(Hill)Tj
1.7461 0 Td
(\(UNC-CH\))Tj
4.8188 0 Td
(approved)Tj
3.9685 0 Td
(this)Tj
1.6781 0 Td
(study.)Tj
-11.0153 -1.2983 Td
(The)Tj
1.7744 0 Td
(Division)Tj
3.6227 0 Td
(of)Tj
1.0035 0 Td
(Laboratory)Tj
4.6374 0 Td
(Animal)Tj
3.2088 0 Td
(Medicine)Tj
3.9855 0 Td
(\(DLAM\))Tj
3.7417 0 Td
(veterinarians,)Tj
5.6409 0 Td
(veterinary)Tj
4.2633 0 Td
(technicians)Tj
-33.0744 -1.3039 Td
(and)Tj
1.7291 0 Td
(laboratory)Tj
4.3483 0 Td
(technicians)Tj
4.7452 0 Td
(supervise)Tj
3.9288 0 Td
(the)Tj
1.4683 0 Td
(health)Tj
2.6759 0 Td
(care)Tj
1.8708 0 Td
(and)Tj
1.7348 0 Td
(humane)Tj
3.498 0 Td
(use)Tj
1.5307 0 Td
(of)Tj
1.0148 0 Td
(all)Tj
1.1508 0 Td
(animals)Tj
3.3279 0 Td
(on)Tj
1.2755 0 Td
(the)Tj
-34.2989 -1.2982 Td
(UNC-CH)Tj
4.1385 0 Td
(campus,)Tj
3.5263 0 Td
(and)Tj
1.7291 0 Td
(have)Tj
2.0579 0 Td
(been)Tj
2.126 0 Td
(accredited)Tj
4.337 0 Td
(by)Tj
1.1849 0 Td
(the)Tj
1.4683 0 Td
(Association)Tj
4.8812 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.4684 0 Td
(Assessment)Tj
4.8642 0 Td
(and)Tj
-33.1651 -1.2983 Td
(Accreditation)Tj
5.6919 0 Td
(of)Tj
1.0148 0 Td
(Laboratory)Tj
4.6431 0 Td
(Animal)Tj
3.2201 0 Td
(Care)Tj
2.1147 0 Td
(International)Tj
5.4821 0 Td
(\(AAALAC\))Tj
4.8416 0 Td
(since)Tj
2.2393 0 Td
(1973.)Tj
2.3471 0 Td
(As)Tj
1.2699 0 Td
(laboratory)Tj
-32.8646 -1.3039 Td
(animal)Tj
2.9706 0 Td
(specialists)Tj
4.1783 0 Td
(they)Tj
1.9219 0 Td
(provide)Tj
3.2881 0 Td
(a)Tj
0.6577 0 Td
(comprehensive)Tj
6.2872 0 Td
(program)Tj
3.7077 0 Td
(of)Tj
1.0148 0 Td
(veterinary)Tj
4.2632 0 Td
(care,)Tj
2.0977 0 Td
(offer)Tj
2.0976 0 Td
(technical)Tj
-32.4848 -1.2983 Td
(advice)Tj
2.7495 0 Td
(and)Tj
1.7292 0 Td
(assistance,)Tj
4.3596 0 Td
(and)Tj
1.7291 0 Td
(provide)Tj
3.2882 0 Td
(laboratory)Tj
4.3483 0 Td
(and)Tj
1.7348 0 Td
(pathology)Tj
4.1726 0 Td
(services)Tj
3.3052 0 Td
(needed)Tj
3.0954 0 Td
(for)Tj
1.389 0 Td
(diagnostic)Tj
-31.9009 -1.2983 Td
(and)Tj
1.7291 0 Td
(research)Tj
3.5546 0 Td
(purposes.)Tj
-4.0875 -1.3039 Td
(Veterinary)Tj
4.507 0 Td
(technicians)Tj
4.7452 0 Td
(make)Tj
2.3924 0 Td
(rounds)Tj
3.0671 0 Td
(through)Tj
3.4412 0 Td
(all)Tj
1.1452 0 Td
(animal)Tj
2.9707 0 Td
(facilities)Tj
3.4979 0 Td
(on)Tj
1.2756 0 Td
(a)Tj
0.652 0 Td
(regular)Tj
3.0614 0 Td
(basis)Tj
2.1486 0 Td
(to)Tj
1.0262 0 Td
(assess)Tj
-35.1267 -1.2982 Td
(the)Tj
1.4683 0 Td
(health)Tj
2.6759 0 Td
(status)Tj
2.5001 0 Td
(of)Tj
1.0148 0 Td
(all)Tj
1.1509 0 Td
(animals.)Tj
3.5546 0 Td
(Animal)Tj
3.2201 0 Td
(husbandry)Tj
4.4787 0 Td
(services)Tj
3.3052 0 Td
(provided)Tj
3.8154 0 Td
(by)Tj
1.1849 0 Td
(DLAM)Tj
3.0671 0 Td
(include:)Tj
3.4129 0 Td
(hous-)Tj
-34.8489 -1.2983 Td
(ing)Tj
1.5023 0 Td
(and)Tj
1.7291 0 Td
(husbandry)Tj
4.4787 0 Td
(services)Tj
3.3052 0 Td
(employing)Tj
4.4674 0 Td
(standardized)Tj
5.3574 0 Td
(food,)Tj
2.2734 0 Td
(bedding,)Tj
3.7134 0 Td
(caging,)Tj
3.05 0 Td
(and)Tj
1.7292 0 Td
(cage)Tj
1.9672 0 Td
(changing)Tj
-33.5733 -1.3039 Td
(intervals,)Tj
3.8494 0 Td
(with)Tj
1.9956 0 Td
(daily)Tj
2.1486 0 Td
(inspections)Tj
4.7452 0 Td
(of)Tj
1.0148 0 Td
(all)Tj
1.1452 0 Td
(cages;)Tj
2.5511 0 Td
(sanitation)Tj
4.1839 0 Td
(of)Tj
1.0148 0 Td
(cages,)Tj
2.5569 0 Td
(equipment)Tj
4.5524 0 Td
(and)Tj
1.7291 0 Td
(animal)Tj
2.9707 0 Td
(rooms;)Tj
-34.4577 -1.2983 Td
(environmental)Tj
6.1114 0 Td
(enrichment;)Tj
5.0967 0 Td
(consultation)Tj
5.1873 0 Td
(on)Tj
1.2756 0 Td
(animal)Tj
2.9707 0 Td
(care)Tj
1.8709 0 Td
(and)Tj
1.7291 0 Td
(use,)Tj
1.7575 0 Td
(breeding,)Tj
3.9798 0 Td
(species)Tj
2.999 0 Td
(selection,)Tj
-32.978 -1.2982 Td
(species)Tj
2.9933 0 Td
(specific)Tj
3.1918 0 Td
(biology)Tj
3.1748 0 Td
(and)Tj
1.7291 0 Td
(health)Tj
2.6816 0 Td
(care,)Tj
2.0976 0 Td
(and)Tj
1.7291 0 Td
(testing)Tj
2.88 0 Td
(of)Tj
1.0148 0 Td
(sentinel)Tj
3.3392 0 Td
(animals)Tj
3.3278 0 Td
(for)Tj
1.389 0 Td
(viral)Tj
1.9899 0 Td
(and)Tj
1.7291 0 Td
(bacterial)Tj
-33.2671 -1.2983 Td
(pathogens,)Tj
4.524 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8255 0 Td
(as)Tj
1.0148 0 Td
(endo)Tj
2.2224 0 Td
(and)Tj
1.7291 0 Td
(ectoparasites.)Tj
-11.1344 -1.3039 Td
(Although)Tj
4.0081 0 Td
(not)Tj
1.5704 0 Td
(required)Tj
3.6397 0 Td
(during)Tj
2.931 0 Td
(this)Tj
1.6724 0 Td
(study,)Tj
2.6135 0 Td
(if)Tj
0.7767 0 Td
(any)Tj
1.6554 0 Td
(animal)Tj
2.9707 0 Td
(had)Tj
1.7122 0 Td
(experienced)Tj
5.0342 0 Td
(pain)Tj
1.9843 0 Td
(or)Tj
1.0998 0 Td
(discomfort)Tj
-32.8646 -1.2983 Td
(that)Tj
1.7744 0 Td
(could)Tj
2.4548 0 Td
(not)Tj
1.5761 0 Td
(be)Tj
1.1508 0 Td
(alleviated)Tj
3.9742 0 Td
(with)Tj
1.9956 0 Td
(standard)Tj
3.7247 0 Td
(analgesics,)Tj
4.405 0 Td
(they)Tj
1.9275 0 Td
(would)Tj
2.7099 0 Td
(have)Tj
2.0636 0 Td
(been)Tj
2.1203 0 Td
(humanely)Tj
4.2009 0 Td
(eutha-)Tj
-34.0778 -1.2983 Td
(nized)Tj
2.398 0 Td
(with)Tj
1.9956 0 Td
(an)Tj
1.2076 0 Td
(overdose)Tj
3.7927 0 Td
(of)Tj
1.0148 0 Td
(inhaled)Tj
3.1975 0 Td
(anesthetic)Tj
4.2236 0 Td
(or)Tj
1.0998 0 Td
(carbon)Tj
3.0104 0 Td
(dioxide,)Tj
3.4299 0 Td
(followed)Tj
3.651 0 Td
(by)Tj
1.1792 0 Td
(a)Tj
0.6519 0 Td
(physical)Tj
3.4526 0 Td
(means)Tj
-34.3046 -1.3039 Td
(of)Tj
1.0147 0 Td
(euthanasia.)Tj
4.6999 0 Td
(All)Tj
1.3946 0 Td
(animals)Tj
3.3335 0 Td
(at)Tj
0.9525 0 Td
(the)Tj
1.4683 0 Td
(end)Tj
1.7178 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(study,)Tj
2.6135 0 Td
(and)Tj
1.7291 0 Td
(any)Tj
1.6555 0 Td
(animal)Tj
2.9706 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.6577 0 Td
(tumor)Tj
2.7439 0 Td
(in)Tj
1.0374 0 Td
(excess)Tj
2.6759 0 Td
(of)Tj
1.0148 0 Td
(1.5)Tj
-36.1641 -1.2982 Td
(cm)Tj
1.4626 0 Td
(diameter)Tj
3.7871 0 Td
(were)Tj
2.1203 0 Td
(humanely)Tj
4.2009 0 Td
(euthanized)Tj
4.6148 0 Td
(as)Tj
1.0148 0 Td
(described)Tj
4.0478 0 Td
(above.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 301.1527 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Optimizin)Tj
4.096 0 Td
(g)Tj
0.7654 0 Td
(ultrasound)Tj
4.8048 0 Td
(molecular)Tj
4.4717 0 Td
(imaging)Tj
3.6496 0 Td
(of)Tj
1.0417 0 Td
(SFRP2)Tj
3.4087 0 Td
(expression)Tj
4.9678 0 Td
(in)Tj
0.9779 0 Td
(angiosa)Tj
3.43 0 Td
(rcoma)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01742)Tj
4.089 0 Td
(81)Tj
0 g
2.0906 0 Td
(March)Tj
2.9622 0 Td
(23,)Tj
1.5874 0 Td
(2017)Tj
34.3562 0 Td
(3)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
BT
66.402 0 Td
(21)Tj
ET
Q
endstream
endobj
52 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 57 0 R/Contents 58 0 R/TrimBox[0 0 612 792]>>
endobj
56 0 obj
<>stream
JFIF C
$, !$4.763.22:ASF:=N>22HbINVX]^]8EfmeZlS[]Y C**Y;2;YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY "
} !1AQa"q2#BR$3br
%&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz
w !1AQaq"2B #3Rbr
$4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ? (
(
(
(
(
(
(
(
(
(5yE\f$*@=hҨc"].kq6 +((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((